Filtros de búsqueda

Lista de obras de

12-Chemokine gene signature identifies lymph node-like structures in melanoma: potential for patient selection for immunotherapy?

artículo científico publicado en 2012

A Comprehensive Approach to Pediatric Atypical Melanocytic Neoplasms with Comment on the Role of Sentinel Lymph Node Biopsy.

artículo científico publicado en 2016

A Phase II trial of vinorelbine tartrate in patients with disseminated malignant melanoma and one prior systemic therapy: a Southwest Oncology Group study

artículo científico

A brief history of melanoma: from mummies to mutations

artículo científico publicado en 2012

A collision of diseases: chronic lymphocytic leukemia discovered during lymph node biopsy for melanoma

artículo científico publicado en 2012

A melanoma odyssey - a conversation with Vernon Sondak about a career in melanoma treatment and research

scientific article published on 01 August 2014

A phase 2 trial of complete resection for stage IV melanoma: results of Southwest Oncology Group Clinical Trial S9430

artículo científico publicado en 2011

A phase II trial of imatinib mesylate in merkel cell carcinoma (neuroendocrine carcinoma of the skin): A Southwest Oncology Group study (S0331)

artículo científico publicado en 2010

A phase II trial of pyrazine diazohydroxide in patients with disseminated malignant melanoma and no prior chemotherapy--Southwest Oncology Group study

artículo científico publicado en 2002

A pooled analysis of eastern cooperative oncology group and intergroup trials of adjuvant high-dose interferon for melanoma

artículo científico publicado en 2004

Activity-Based Protein Profiling Shows Heterogeneous Signaling Adaptations to BRAF Inhibition

artículo científico publicado en 2016

Adjuvant Immunotherapy and Radiation in the Management of High-risk Resected Melanoma.

artículo científico publicado en 2010

Adjuvant Radiation Therapy and Chemotherapy in Merkel Cell Carcinoma: Survival Analyses of 6908 Cases From the National Cancer Data Base

artículo científico publicado en 2016

Adjuvant and Neoadjuvant Therapy in High-Risk Stage III Cutaneous Melanoma

artículo científico publicado en 2017

Adjuvant immunotherapy for cancer: the next step

artículo científico publicado en 2015

Adjuvant immunotherapy of resected, intermediate-thickness, node-negative melanoma with an allogeneic tumor vaccine: impact of HLA class I antigen expression on outcome.

artículo científico publicado en 2002

Adjuvant immunotherapy of resected, intermediate-thickness, node-negative melanoma with an allogeneic tumor vaccine: overall results of a randomized trial of the Southwest Oncology Group

artículo científico publicado en 2002

Adjuvant interferon: recommit or move on? ⬇️

artículo científico publicado el 20 de enero de 2011

Adjuvant therapy for melanoma: a surgical perspective

scientific article published on January 2011

Adjuvant therapy of melanoma: is pegylated interferon alfa-2b what we've been waiting for?

artículo científico publicado en 2008

Adjuvant vaccine immunotherapy of resected, clinically node-negative melanoma: long-term outcome and impact of HLA class I antigen expression on overall survival

artículo científico publicado en 2014

Advances in the understanding and treatment of melanoma -- Keystone Symposium.

artículo científico publicado en 2006

Age as a predictor of sentinel node metastasis among patients with localized melanoma: an inverse correlation of melanoma mortality and incidence of sentinel node metastasis among young and old patients

artículo científico publicado en 2014

Age as a prognostic factor in patients with localized melanoma and regional metastases

artículo científico publicado en 2013

Age-specific seroprevalence of Merkel cell polyomavirus, BK virus, and JC virus

artículo científico

Allogeneic and autologous melanoma vaccines: where have we been and where are we going?

artículo científico publicado en 2006

An update on the Society for Immunotherapy of Cancer consensus statement on tumor immunotherapy for the treatment of cutaneous melanoma: version 2.0.

artículo científico publicado en 2018

Are we there yet? Prolonged MAPK inhibition in BRAF(V600)-mutant melanoma.

artículo científico publicado en 2016

BRAF inhibition for advanced locoregional BRAF V600E mutant melanoma: a potential neoadjuvant strategy

artículo científico publicado en 2016

BRAF-MEK inhibition in melanoma brain metastases: a new hope

artículo científico publicado en 2017

Behavior of Cutaneous Adnexal Malignancies: a Single Institution Experience

scientific article published on 14 June 2018

Both tumor depth and diameter are predictive of sentinel lymph node status and survival in Merkel cell carcinoma

artículo científico publicado en 2015

CTLA-4 blockade with monoclonal antibodies in patients with metastatic cancer: surgical issues

scientific article published on 21 August 2008

Case-control study of Merkel cell polyomavirus infection and cutaneous squamous cell carcinoma

artículo científico publicado en 2011

Case-control study of cutaneous human papillomavirus infection in Basal cell carcinoma of the skin

artículo científico publicado en 2013

Case-control study of cutaneous human papillomaviruses in squamous cell carcinoma of the skin

artículo científico publicado en 2012

Case-control study of genus-beta human papillomaviruses in plucked eyebrow hairs and cutaneous squamous cell carcinoma

artículo científico publicado en 2013

Case-control study of smoking and non-melanoma skin cancer

artículo científico publicado en 2011

Ceritinib Enhances the Efficacy of Trametinib in BRAF/NRAS-Wild-Type Melanoma Cell Lines

artículo científico publicado en 2017

Chemoprevention agents for melanoma: a path forward into phase 3 clinical trials

artículo científico publicado en 2018

Chemoprevention of melanoma: theoretical and practical considerations

artículo científico publicado en 2005

Chemotherapy for metastatic melanoma: time for a change?

artículo científico publicado en 2007

Clinical Characteristics and Outcomes for Solitary Fibrous Tumor (SFT): A Single Center Experience

artículo científico publicado en 2015

Clinicopathologic predictors of sentinel lymph node metastasis in thin melanoma

artículo científico publicado en 2013

Clinicopathologic predictors of survival in patients with desmoplastic melanoma

artículo científico publicado en 2015

Clonal architectures and driver mutations in metastatic melanomas

artículo científico publicado en 2014

Combination Therapies for Melanoma: A New Standard of Care?

artículo científico publicado en 2016

Combination of Ipilimumab and Adoptive Cell Therapy with Tumor-Infiltrating Lymphocytes for Patients with Metastatic Melanoma.

artículo científico publicado en 2018

Combination of external beam radiotherapy (EBRT) with intratumoral injection of dendritic cells as neo-adjuvant treatment of high-risk soft tissue sarcoma patients

artículo científico publicado en 2011

Combined BRAF and HSP90 Inhibition in Patients with Unresectable -Mutant Melanoma

Combined analysis of phase III trials evaluating [⁹⁹mTc]tilmanocept and vital blue dye for identification of sentinel lymph nodes in clinically node-negative cutaneous melanoma

artículo científico publicado en 2012

Comparison of Single-Photon Emission Computed Tomography-Computed Tomography (SPECT/CT) and Conventional Planar Lymphoscintigraphy for Sentinel Node Localization in Patients with Cutaneous Malignancies.

artículo científico publicado en 2016

Completely regressed cutaneous melanocytic lesion revisited

artículo científico publicado en 2009

Completion lymphadenectomy for a positive sentinel node biopsy in melanoma patients is not associated with a survival benefit

artículo científico publicado en 2019

Conjunctival melanomas harbor BRAF and NRAS mutations--Letter

artículo científico publicado en 2013

Controversies in the evaluation and management of atypical melanocytic proliferations in children, adolescents, and young adults

artículo científico publicado en 2013

Correlation of molecular human leukocyte antigen typing and outcome in high-risk melanoma patients receiving adjuvant interferon.

artículo científico publicado en 2010

Current Immunotherapy Practices in Melanoma

scientific article published on 12 April 2019

Current and planned multicenter trials for patients with primary or metastatic melanoma

artículo científico publicado en 2011

Current status of biomarkers for melanoma metastasis.

artículo científico publicado en 2006

Cutaneous Human Papillomavirus Infection and Development of Subsequent Squamous Cell Carcinoma of the Skin

artículo científico publicado en 2016

Cutaneous angiosarcoma of the scalp: a multidisciplinary approach

artículo científico publicado en 2003

Cutaneous angiosarcoma: a single-institution experience

artículo científico publicado en 2013

Cutaneous leiomyosarcoma: treatment and outcomes with a standardized margin of resection

artículo científico publicado en 2013

Cutaneous melanoma: methods of biopsy and definitive surgical excision

artículo científico publicado en 2005

Cutaneous melanoma: pathogenesis and rationale for chemoprevention

artículo científico publicado en 2005

Cutaneous viral infections associated with ultraviolet radiation exposure

scientific article published on 20 August 2020

Cytoreductive surgery for melanoma

artículo científico publicado en 2007

Dermal melanoma: A report on prognosis, outcomes, and the utility of sentinel lymph node biopsy

artículo científico publicado en 2015

Dermatofibrosarcoma protuberans: how wide should we resect?

artículo científico publicado en 2010

Desmoplastic and neurotropic melanoma

artículo científico publicado en 2004

Desmoplastic melanoma: is there a role for sentinel lymph node biopsy?

artículo científico publicado en 2013

Detection of copy number alterations in metastatic melanoma by a DNA fluorescence in situ hybridization probe panel and array comparative genomic hybridization: a southwest oncology group study (S9431).

artículo científico

Down-regulation of pro-apoptotic genes is an early event in the progression of malignant melanoma.

artículo científico publicado en 2006

Echoes of a failure: what lessons can we learn?

artículo científico publicado en 2019

Efficacy of adoptive cell transfer of tumor-infiltrating lymphocytes after lymphopenia induction for metastatic melanoma

artículo científico publicado en 2012

Emergence of a squamous cell carcinoma phenotype following treatment of metastatic basal cell carcinoma with vismodegib

artículo científico publicado en 2013

Erratum to: Progression of cutaneous melanoma: implications fortreatment.

artículo científico publicado en 2012

Evaluating melanoma drug response and therapeutic escape with quantitative proteomics

artículo científico publicado en 2014

Evaluation of interferon alpha-2B and thalidomide in patients with disseminated malignant melanoma, phase 2, SWOG 0026.

artículo científico publicado en 2007

Evaluation of staging chest radiographs and serum lactate dehydrogenase for localized melanoma

artículo científico publicado en 2004

Evidence-based clinical practice guidelines on the use of sentinel lymph node biopsy in melanoma

artículo científico publicado en 2013

Expanded access programmes: patient interests versus clinical trial integrity

artículo científico publicado en 2014

Expression of CXCR4, E-cadherin, Bcl-2, and survivin in Merkel cell carcinoma: an immunohistochemical study using a tissue microarray

artículo científico publicado en 2012

Expression of receptor tyrosine kinases epidermal growth factor receptor and HER-2/neu in synovial sarcoma

artículo científico

Extending the reach of BRAF-targeted cancer therapy

scientific article published on 01 May 2012

Factors predicting survival in thick melanoma: Do all thick melanomas have the same prognosis?

artículo científico publicado en 2020

Feasibility of serial biopsies of large dysplastic nevi as a melanoma chemoprevention model

artículo científico publicado en 2011

Frontline approach to metastatic BRAF-mutant melanoma diagnosis, molecular evaluation, and treatment choice

artículo científico publicado en 2014

Full-thickness grafts procured from skin overlying the sentinel lymph node basin; reconstruction of primary cutaneous malignancy excision defects

scientific article published on 01 April 2008

Gender Disparities in Patients With Melanoma: Breaking the Glass Ceiling

artículo científico publicado en 2012

Gene variants in angiogenesis and lymphangiogenesis and cutaneous melanoma progression

artículo científico publicado en 2013

Genomic analysis of a case of agminated Spitz nevi and congenital-pattern nevi arising in extensive nevus spilus.

artículo científico publicado en 2017

Granulocyte-macrophage-colony-stimulating factor added to a multipeptide vaccine for resected Stage II melanoma

artículo científico publicado en 2003

HDAC8 Regulates a Stress Response Pathway in Melanoma to Mediate Escape from BRAF Inhibitor Therapy

artículo científico publicado en 2019

Has targeted therapy for melanoma made chemotherapy obsolete?

artículo científico publicado en 2013

High frequency of brain metastases after adjuvant therapy for high-risk melanoma

artículo científico publicado en 2017

Higher than reported adolescent and young adult clinical trial enrollment during the "Golden Age" of melanoma clinical trials.

artículo científico publicado en 2018

How do we know when a lymph node dissection is adequate?

artículo científico publicado en 2011

How does interferon work? Does it even matter?

artículo científico publicado en 2002

How well are we taking care of melanoma patients in the USA?

scientific article published on 09 July 2008

Identifying risk factors using a skin cancer screening program

artículo científico publicado en 2013

Immunostaining for cytokeratin 20 improves detection of micrometastatic Merkel cell carcinoma in sentinel lymph nodes

scientific article published on 01 May 2002

Improved local and regional control with radiotherapy for Merkel cell carcinoma of the head and neck

artículo científico publicado en 2016

Improved survival of patients with melanoma brain metastases in the era of targeted BRAF and immune checkpoint therapies.

artículo científico publicado en 2017

Improving patient outcomes to targeted therapies in melanoma

artículo científico publicado en 2016

In vivo and in silico pharmacokinetics and biodistribution of a melanocortin receptor 1 targeted agent in preclinical models of melanoma

scientific article published on 08 July 2013

Inactivation of RASA1 promotes melanoma tumorigenesis via R-Ras activation.

scientific article published on 16 March 2016

Indications and options for systemic therapy in melanoma

artículo científico

Individualizing follow-up for patients with early-stage melanoma

artículo científico publicado en 2011

Inhibition of BRAF and MEK in BRAF-mutant melanoma

artículo científico publicado en 2015

Inhibition of HSP90 by AT13387 delays the emergence of resistance to BRAF inhibitors and overcomes resistance to dual BRAF and MEK inhibition in melanoma models

artículo científico publicado en 2014

Inhibition of Wee1, AKT, and CDK4 underlies the efficacy of the HSP90 inhibitor XL888 in an in vivo model of NRAS-mutant melanoma

artículo científico publicado en 2013

Inhibition of autophagy enhances the effects of the AKT inhibitor MK-2206 when combined with paclitaxel and carboplatin in BRAF wild-type melanoma.

artículo científico publicado en 2014

Innovations and challenges in melanoma: summary statement from the first Cambridge conference

artículo científico publicado en 2006

Integrating molecular biomarkers into current clinical management in melanoma

artículo científico

Interferon alfa-2a for melanoma metastases.

artículo científico publicado en 2002

Interferon is associated with improved survival for node-positive cutaneous melanoma: a single-institution experience

scholarly article by Daniel E Oliver et al published June 2018 in Melanoma management

Introduction: Advanced cutaneous malignancies

scientific article published on 01 April 2012

Ipilimumab alone or in combination with nivolumab after progression on anti-PD-1 therapy in advanced melanoma

artículo científico publicado en 2017

Ipilimumab.

artículo científico publicado en 2011

Is There a Role for Adjuvant High-Dose Interferon-??-2b in the Management of Melanoma?

artículo científico publicado el 1 de enero de 2003

Is a Wider Margin (2 cm vs. 1 cm) for a 1.01-2.0 mm Melanoma Necessary?

artículo científico publicado en 2016

Is there a role for sentinel lymph node biopsy in the management of sarcoma?

artículo científico publicado en 2003

Joint melanoma meetings in Tampa enhance communication and collaboration

Laboratory and clinical evidence of synergistic cytotoxicity of sequential treatment with gemcitabine followed by docetaxel in the treatment of sarcoma

artículo científico publicado en 2004

Leveraging transcriptional dynamics to improve BRAF inhibitor responses in melanoma

scientific article published on 05 October 2019

Ligand-independent EPHA2 signaling drives the adoption of a targeted therapy-mediated metastatic melanoma phenotype

artículo científico publicado en 2014

Limiting the morbidity of inguinal lymphadenectomy for metastatic melanoma

artículo científico publicado en 2009

Long-term outcomes after radiotherapy for retroperitoneal and deep truncal sarcoma.

artículo científico publicado en 2007

Low recurrence rate after surgery for dermatofibrosarcoma protuberans: a multidisciplinary approach from a single institution

artículo científico publicado en 2004

Lymphangiogenesis: host and tumor factors in nodal metastasis

artículo científico publicado en 2008

Lymphatic mapping and sentinel lymph node biopsy in the detection of early metastasis from sweat gland carcinoma ⬇️

artículo científico publicado el 1 de mayo de 2003

Malignant melanoma: current state of primary and adjuvant treatment

artículo científico publicado en 2003

Management of Sentinel Lymph Node Metastasis in Merkel Cell Carcinoma: Completion Lymphadenectomy, Radiation, or Both?

artículo científico publicado en 2018

Management of familial melanoma and nonmelanoma skin cancer syndromes

scientific article published on January 2009

Management of intussusception in patients with melanoma

scientific article published on 07 February 2019

Markers and Tissue Resources for Melanoma: Meeting Report

scientific article published on 01 November 2006

Measures of cutaneous human papillomavirus infection in normal tissues as biomarkers of HPV in corresponding nonmelanoma skin cancers

artículo científico publicado en 2008

Meeting report from the Third Global Workshop on Melanoma.

artículo científico publicado en 2010

Meeting report: consensus from the first and second Global Workshops in Melanoma November 19-20, 2008

Melacine: an allogeneic melanoma tumor cell lysate vaccine

artículo científico publicado en 2003

Melanoma Prevention-Avoiding Indoor Tanning and Minimizing Overexposure to the Sun.

artículo científico publicado en 2016

Melanoma and human leukocyte antigen status: the missing link?

artículo científico publicado en 2002

Melanoma central nervous system metastases: An update to approaches, challenges, and opportunities

scientific article published on 19 February 2019

Melanoma in the brain: biology and therapeutic options

artículo científico publicado en 2012

Melanoma margins: the importance and need for more evidence-based trials

artículo científico publicado en 2004

Melanoma staging: Evidence-based changes in the American Joint Committee on Cancer eighth edition cancer staging manual

artículo científico publicado en 2017

Melanoma vaccines: breakthrough or bust?

artículo científico publicado en 2002

Melanoma--an unlikely poster child for personalized cancer therapy.

artículo científico publicado en 2010

Melanoma: Adjuvant therapy and other treatment options ⬇️

artículo científico publicado el 1 de junio de 2003

Melanoma: MSLT-1--putting sentinel lymph node biopsy into context

artículo científico publicado en 2014

Merkel cell carcinoma and immunosuppression: what we still need to know

scientific article published on 08 January 2015

Merkel cell carcinoma of unknown primary origin

artículo científico publicado en 2012

Merkel cell carcinoma: pathologic findings and prognostic factors

artículo científico publicado en 2010

Merkel cell polyomavirus (MCV) T-antigen seroreactivity, MCV DNA in eyebrow hairs, and squamous cell carcinoma

artículo científico publicado en 2015

Meta-analysis of phase II cooperative group trials in metastatic stage IV melanoma to determine progression-free and overall survival benchmarks for future phase II trials

artículo científico

Metastasectomy for distant metastatic melanoma: analysis of data from the first Multicenter Selective Lymphadenectomy Trial (MSLT-I)

artículo científico publicado en 2012

Metastatic nevoid melanoma in a 4 1/2-year-old child

artículo científico publicado en 2003

Microsatellitosis in Patients with Melanoma

artículo científico publicado en 2018

Minimizing Morbidity while Preserving Outcome after Inguinal Lymphadenectomy: Navigating between Scylla and Charybdis ⬇️

artículo científico publicado el 1 de abril de 2011

Mitotic rate and younger age are predictors of sentinel lymph node positivity: lessons learned from the generation of a probabilistic model

artículo científico publicado en 2004

Modulation of Janus kinase 2 by cisplatin in cancer cells

artículo científico publicado en 2004

Multidisciplinary management of special melanoma situations: oligometastatic disease and bulky nodal sites

artículo científico publicado en 2007

Multimodality management of desmoid tumors: how important is a negative surgical margin?

artículo científico publicado en 2008

Multivariate analysis of prognostic factors among 2,313 patients with stage III melanoma: comparison of nodal micrometastases versus macrometastases

artículo científico publicado en 2010

Neoadjuvant BRAF-targeted therapy in regionally advanced and oligometastatic melanoma

artículo científico publicado en 2019

Neoadjuvant Checkpoint Inhibitor Therapy for Merkel Cell Carcinoma

artículo científico publicado en 2020

Neoadjuvant systemic therapy in melanoma: recommendations of the International Neoadjuvant Melanoma Consortium

scientific article published on 01 July 2019

New challenges in endpoints for drug development in advanced melanoma

artículo científico publicado en 2011

Nonsentinel node metastases in melanoma: do they reflect the biology of the tumor, the lymph node or the surgeon? : Editorial to Accompany Ghaferi et al., ASO-2009-03-0312.R1.

artículo científico publicado en 2009

Nonsurgical treatment options for Basal cell carcinoma

artículo científico publicado en 2011

Novel treatments for melanoma brain metastases

artículo científico publicado en 2013

Occult primary cancer clinical practice guidelines

artículo científico publicado en 2005

Overall and progression-free survival in metastatic melanoma: analysis of a single-institution database

artículo científico publicado en 2006

Overestimation of Risk for Sentinel Lymph Node Metastasis in a Nomogram for T1 Melanomas

scientific article published on 23 July 2020

PTEN loss confers BRAF inhibitor resistance to melanoma cells through the suppression of BIM expression

artículo científico publicado en 2011

Paradoxical oncogenesis--the long-term effects of BRAF inhibition in melanoma

artículo científico publicado en 2013

Pathologic nodal evaluation improves prognostic accuracy in Merkel cell carcinoma: analysis of 5823 cases as the basis of the first consensus staging system

artículo científico publicado en 2010

Pathology review of thin melanoma and melanoma in situ in a multidisciplinary melanoma clinic: impact on treatment decisions

artículo científico publicado en 2009

Patterns and timing of sunlight exposure and risk of basal cell and squamous cell carcinomas of the skin--a case-control study

artículo científico publicado en 2012

Pediatric Melanoma and Atypical Melanocytic Neoplasms.

artículo científico publicado en 2016

Pediatric melanoma: analysis of an international registry

artículo científico publicado en 2013

Pegylated interferon for the adjuvant treatment of melanoma: FDA approved, but what is its role?

artículo científico publicado en 2012

Pegylated interferons: prospects for the use in the adjuvant and palliative therapy of metastatic melanoma

artículo científico publicado en 2010

Perioperative Outcomes of Melanoma Patients Undergoing Surgery After Receiving Immunotherapy or Targeted Therapy

scientific article published on 01 April 2020

Phase 2 study of RO4929097, a gamma-secretase inhibitor, in metastatic melanoma: SWOG 0933.

artículo científico publicado en 2014

Phase 2 trial of combination thalidomide plus temozolomide in patients with metastatic malignant melanoma: Southwest Oncology Group S0508.

artículo científico publicado en 2010

Phase I trial of interleukin-12 plasmid electroporation in patients with metastatic melanoma

artículo científico publicado en 2008

Phase II study of 9-nitro-camptothecin in patients with advanced chordoma or soft tissue sarcoma

artículo científico publicado en 2005

Phase II trial of sorafenib in combination with carboplatin and paclitaxel in patients with metastatic uveal melanoma: SWOG S0512.

artículo científico publicado en 2012

Phase III Randomized Study of 4 Weeks of High-Dose Interferon-α-2b in Stage T2bNO, T3a-bNO, T4a-bNO, and T1-4N1a-2a (microscopic) Melanoma: A Trial of the Eastern Cooperative Oncology Group-American College of Radiology Imaging Network Cancer Resear

artículo científico publicado en 2017

Phase III Study of Adjuvant Ipilimumab (3 or 10 mg/kg) Versus High-Dose Interferon Alfa-2b for Resected High-Risk Melanoma: North American Intergroup E1609

artículo científico publicado en 2019

Phase III trial comparing concurrent biochemotherapy with cisplatin, vinblastine, dacarbazine, interleukin-2, and interferon alfa-2b with cisplatin, vinblastine, and dacarbazine alone in patients with metastatic malignant melanoma (E3695): a trial c

artículo científico publicado en 2008

Phenotypic and functional analysis of dendritic cells and clinical outcome in patients with high-risk melanoma treated with adjuvant granulocyte macrophage colony-stimulating factor

scientific article published on 01 July 2008

Point: Interferon-alpha for adjuvant therapy for melanoma patients.

artículo científico publicado en 2004

Point: Surgical Management of Lymph Node Basin in Sentinel Lymph Node-Positive Melanoma

artículo científico publicado en 2016

Pre-SN Ultrasound-FNAC for Lymph Node Metastases in Melanoma Patients: A Reply

artículo científico publicado en 2017

Prediction is Difficult, Especially About the Future: Clinical Prognostic Tools in Melanoma

artículo científico publicado en 2016

Predictors of nonsentinel lymph node positivity in patients with a positive sentinel node for melanoma

artículo científico publicado en 2005

Preoperative ultrasound is not useful for identifying nodal metastasis in melanoma patients undergoing sentinel node biopsy: preoperative ultrasound in clinically node-negative melanoma

artículo científico publicado en 2011

Primary tumor thickness as a prognostic factor in Merkel cell carcinoma: the next big thing?

artículo científico publicado en 2012

Prognostic Gene Expression Profiling in Cutaneous Melanoma: Identifying the Knowledge Gaps and Assessing the Clinical Benefit

artículo científico publicado en 2020

Prognostic significance of mitotic rate in localized primary cutaneous melanoma: an analysis of patients in the multi-institutional American Joint Committee on Cancer melanoma staging database

artículo científico publicado en 2011

Progression of cutaneous melanoma: implications for treatment

artículo científico publicado en 2012

Proper margins of excision in dermatofibrosarcoma protuberans: wide or narrow?

artículo científico publicado en 2008

Pros and Cons of Adjuvant Interferon in the Treatment of Melanoma ⬇️

artículo científico publicado el 1 de enero de 2003

RE: A comparison of survival rates for treatment of melanoma metastatic to the brain

artículo científico publicado en 2004

Radiation Therapy is Associated with Improved Outcomes in Merkel Cell Carcinoma.

artículo científico publicado en 2016

Radiotherapy influences local control in patients with desmoplastic melanoma

artículo científico publicado en 2013

Randomized phase II evaluation of 6 g/m2 of ifosfamide plus doxorubicin and granulocyte colony-stimulating factor (G-CSF) compared with 12 g/m2 of ifosfamide plus doxorubicin and G-CSF in the treatment of poor-prognosis soft tissue sarcoma

artículo científico publicado en 2005

Randomized phase II trial of sorafenib with temsirolimus or tipifarnib in untreated metastatic melanoma (S0438).

artículo científico publicado en 2012

Re-biopsy of partially sampled thin melanoma impacts sentinel lymph node sampling as well as surgical margins

artículo científico publicado en 2019

Recurrence of Melanoma After a Negative Sentinel Node Biopsy: Predictors and Impact of Recurrence Site on Survival

scientific article published on 22 April 2019

Refining the criteria for sentinel lymph node biopsy in patients with thinner melanoma: a roadmap for the future.

artículo científico publicado en 2010

Regional Node Basin Recurrence in Melanoma Patients: More Common After Node Dissection for Macroscopic Rather than Clinically Occult Nodal Disease

artículo científico publicado en 2019

Regional Radiation Therapy Impacts Outcome for Node-Positive Cutaneous Melanoma

artículo científico publicado en 2017

Relationships among primary tumor size, number of involved nodes, and survival for 8044 cases of Merkel cell carcinoma

artículo científico publicado en 2014

Reply to Improving the survival of patients with American Joint Committee on Cancer stage III and IV melanoma.

artículo científico publicado en 2018

Resection Margins in Merkel Cell Carcinoma: Is a 1-cm Margin Wide Enough?

artículo científico publicado en 2018

Resection of Gastrointestinal Metastases in Stage IV Melanoma: Correlation with Outcomes

artículo científico publicado en 2016

Resistance patterns to anti-PD-1 therapy in metastatic melanoma.

artículo científico publicado en 2016

Response of extraabdominal desmoid tumors to therapy with imatinib mesylate

artículo científico publicado en 2002

Results of clinical trials with an allogenic melanoma tumor cell lysate vaccine: Melacine

artículo científico publicado en 2003

Retroperitoneal sarcomas

artículo científico publicado en 2005

Review of the 25th annual scientific meeting of the International Society for Biological Therapy of Cancer ⬇️

artículo científico publicado en 2011

Risk assessment in localized primary cutaneous melanoma: a Southwest Oncology Group study evaluating nine factors and a test of the Clark logistic regression prediction model

scientific article published on 01 October 2002

Risk-stratified screening for detection of melanoma

scientific article published on 01 February 2015

Robotic-Assisted Transperitoneal Pelvic Lymphadenectomy for Metastatic Melanoma: Early Outcomes Compared with Open Pelvic Lymphadenectomy.

artículo científico publicado en 2016

Routine biopsy of cloquet's node is of limited value in sentinel node positive melanoma patients ⬇️

artículo científico publicado el 15 de septiembre de 2010

Routine omission of sentinel lymph node biopsy for merkel cell carcinoma <= 1 cm is not justified

artículo científico publicado en 2009

Selecting Patients With Thin Melanoma for Sentinel Lymph Node Biopsy-This Time It's Personal

artículo científico publicado en 2017

Sentinel Lymph Node Biopsy Is Prognostic in Thickest Melanoma Cases and Should Be Performed for Thick Melanomas

scientific article published on 10 June 2020

Sentinel lymph node biopsy as the standard of care for cutaneous melanoma

artículo científico publicado en 2007

Sentinel lymph node biopsy for melanoma: indications and rationale

artículo científico publicado en 2009

Sentinel lymph node biopsy for patients with problematic spitzoid melanocytic lesions: a report on 18 patients

artículo científico publicado en 2003

Sentinel lymph node biopsy in melanoma: Facts and controversies

artículo científico publicado en 2010

Sentinel lymph node biopsy is indicated for patients with thick clinically lymph node-negative melanoma

artículo científico publicado en 2015

Sentinel node biopsy and standard of care for melanoma.

artículo científico publicado en 2009

Sentinel node biopsy for thin melanomas: which patients should be considered?

artículo científico publicado en 2005

Sentinel node biopsy in atypical melanocytic neoplasms in childhood: a single institution experience in 24 patients

artículo científico publicado en 2012

Sentinel node biopsy is indicated for thin melanomas ≥0.76 mm

artículo científico publicado en 2012

Setting the bar for adjuvant treatment of melanoma

artículo científico publicado en 2014

Shave biopsy is a safe and accurate method for the initial evaluation of melanoma

artículo científico publicado en 2011

Single-institution outcome experience using AlloDerm® as temporary coverage or definitive reconstruction for cutaneous and soft tissue malignancy defects

artículo científico publicado en 2013

Skin cancer screening: recommendations for data-driven screening guidelines and a review of the US Preventive Services Task Force controversy

artículo científico publicado en 2017

Southwest Oncology Group S0008: a phase III trial of high-dose interferon Alfa-2b versus cisplatin, vinblastine, and dacarbazine, plus interleukin-2 and interferon in patients with high-risk melanoma--an intergroup study of cancer and leukemia Group

artículo científico publicado en 2014

Staging workup, sentinel node biopsy, and follow-up tests for melanoma: update of current concepts

artículo científico publicado en 2004

Standard immunostains for melanoma in sentinel lymph node specimens: which ones are most useful?

artículo científico publicado en 2004

State of the science 60th anniversary review: 60 Years of advances in cutaneous melanoma epidemiology, diagnosis, and treatment, as reported in the journal Cancer.

artículo científico publicado en 2008

Stratifying SLN incidence in intermediate thickness melanoma patients.

artículo científico publicado en 2017

Sunlight exposure and cutaneous human papillomavirus seroreactivity in basal cell and squamous cell carcinomas of the skin

artículo científico publicado en 2012

Surgical management of melanoma

artículo científico publicado en 2018

Surgical management of melanoma

artículo científico publicado en 2014

Surgical management of melanoma-in-situ using a staged marginal and central excision technique

artículo científico publicado en 2008

Surgical therapy of cutaneous melanoma

artículo científico publicado en 2007

Surgically Unresectable Regional Melanoma Metastases in a Patient With Renal Failure and Peripheral Vascular Disease: Are There Safe and Potentially Effective Treatments? ⬇️

artículo científico publicado el 1 de agosto de 2010

Synthesis and characterization of a melanoma-targeted fluorescence imaging probe by conjugation of a melanocortin 1 receptor (MC1R) specific ligand

artículo científico publicado en 2012

Systemic Therapy for Melanoma: ASCO Guideline

scientific article published on 31 March 2020

Targeted therapies: Improved outcomes for patients with metastatic melanoma

artículo científico publicado en 2011

Targeted therapy for melanoma: is double hitting a home run?

artículo científico publicado en 2012

Targeted therapy in melanoma

artículo científico publicado en 2013

Targeting events in melanoma carcinogenesis for the prevention of melanoma

artículo científico publicado en 2006

Targeting mutant BRAF and KIT in metastatic melanoma: ASCO 2009 meeting report.

artículo científico publicado en 2009

Telomere length and risk of melanoma, squamous cell carcinoma, and basal cell carcinoma

artículo científico publicado en 2013

The Florida Melanoma Trial I: A Prospective Multicenter Phase I/II Trial of Postoperative Hypofractionated Adjuvant Radiotherapy with Concurrent Interferon-Alfa-2b in the Treatment of Advanced Stage III Melanoma with Long-Term Toxicity Follow-Up

article

The Genomic Landscape of Merkel Cell Carcinoma and Clinicogenomic Biomarkers of Response to Immune Checkpoint Inhibitor Therapy

scientific article published on 09 August 2019

The HSP90 inhibitor XL888 overcomes BRAF inhibitor resistance mediated through diverse mechanisms

artículo científico publicado en 2012

The Society for Immunotherapy of Cancer consensus statement on tumour immunotherapy for the treatment of cutaneous melanoma

artículo científico publicado en 2013

The association of MUC16 mutation with tumor mutation burden and its prognostic implications in cutaneous melanoma

artículo científico publicado en 2020

The challenge of defining guidelines for sentinel lymph node biopsy in patients with thin primary cutaneous melanomas

artículo científico publicado en 2012

The contoured staged marginal and central surgical excision technique with en face histopathological analysis: useful additions in the armamentarium for treating and diagnosing melanoma in situ

article

The future of targeted therapy approaches in melanoma.

artículo científico

The impact of factors beyond Breslow depth on predicting sentinel lymph node positivity in melanoma

artículo científico publicado en 2007

The role of radiation therapy in the management of cutaneous melanoma

artículo científico publicado en 2011

The role of sentinel lymph node biopsy for melanoma: evidence assessment

artículo científico publicado en 2005

The sentinel lymph node: more than just another blue lymph node

artículo científico publicado en 2003

The surgical management of primary and metastatic Merkel cell carcinoma

artículo científico publicado en 2010

The unique clinical characteristics of melanoma diagnosed in children

artículo científico publicado en 2012

The value of sentinel lymph node biopsy in the management of head and neck melanoma

scientific article published on 01 May 2007

Therapeutic potential of directed tyrosine kinase inhibitor therapy in sarcomas

artículo científico publicado en 2008

Thin primary cutaneous melanomas: associated detection patterns, lesion characteristics, and patient characteristics

scientific article published on 01 October 2002

Treatment of Head and Neck Melanoma In Situ With Staged Contoured Marginal Excisions

artículo científico publicado en 2016

Treatment options for limited or symptomatic metastatic melanoma

artículo científico publicado en 2008

Tumor vaccines: a role in preventing recurrence in melanoma?

artículo científico publicado en 2002

Unanswered questions about margin recommendations for primary cutaneous melanoma

artículo científico publicado en 2012

Unanswered questions in the management of stage I-III Merkel cell carcinoma

artículo científico

Unusual presentations of melanoma: melanoma of unknown primary site, melanoma arising in childhood, and melanoma arising in the eye and on mucosal surfaces

artículo científico

Use and abuse of statistics in evidence-based medicine.

artículo científico publicado en 2002

Useof anti-phosphohistone H3 immunohistochemistry to determine mitotic rate in thin melanoma

scientific article published on 01 October 2010

Viruses in Skin Cancer (VIRUSCAN): Study Design and Baseline Characteristics of a Prospective Clinic-Based Cohort Study

scientific article published on 19 August 2019

Vitamin D and Melanoma: What Do We Tell Our Patients?

scientific article published on 04 April 2016

What is the significance of the in transit or interval sentinel node in melanoma?

artículo científico publicado en 2011

When will melanoma vaccines be proven effective?

artículo científico publicado en 2003

Where to start with systemic melanoma therapy?

article by Geoffrey T Gibney et al published August 2014 in Melanoma management

Who is to blame for false-negative sentinel node biopsies in melanoma?

artículo científico publicado en 2010

Wnt5A regulates expression of tumor-associated antigens in melanoma via changes in signal transducers and activators of transcription 3 phosphorylation.

artículo científico publicado en 2008

XL888 Limits Vemurafenib-Induced Proliferative Skin Events by Suppressing Paradoxical MAPK Activation

artículo científico publicado en 2015

c-KIT signaling as the driving oncogenic event in sub-groups of melanomas

artículo científico publicado en 2009

Dominio Público Uruguay está sostenido por:

Acerca de Dominio Público Uruguay

Ayuda